AM-2201

CAS No. 335161-24-5

AM-2201( AM 2201 | AM2201 )

Catalog No. M14138 CAS No. 335161-24-5

A synthetic cannabinoid that acts as a potent, nonselective full agonist for the cannabinoid receptor with EC50 of 38 and 58 nM for CB1 and CB2, respectively.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    AM-2201
  • Note
    Research use only, not for human use.
  • Brief Description
    A synthetic cannabinoid that acts as a potent, nonselective full agonist for the cannabinoid receptor with EC50 of 38 and 58 nM for CB1 and CB2, respectively.
  • Description
    A synthetic cannabinoid that acts as a potent, nonselective full agonist for the cannabinoid receptor with EC50 of 38 and 58 nM for CB1 and CB2, respectively; dose-dependently induces hypothermia and reduces heart rate at doses of 0.3-10 mg/kg in mice.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    AM 2201 | AM2201
  • Pathway
    GPCR/G Protein
  • Target
    Cannabinoid Receptor
  • Recptor
    Cannabinoid Receptor
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    335161-24-5
  • Formula Weight
    359.4
  • Molecular Formula
    C24H22FNO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    c1ccc2c(c1)cccc2C(=O)c3cn(c4c3cccc4)CCCCCF
  • Chemical Name
    [1-(5-fluoropentyl)-1H-indol-3-yl](naphthalene-1-yl)methanone

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. McQuade D, et al. Eur J Clin Pharmacol. 2013 Mar;69(3):373-6. 2. Sobolevsky T, et al. Drug Test Anal. 2012 Oct;4(10):745-53. 3. Banister SD, et al. ACS Chem Neurosci. 2015 Aug 19;6(8):1445-58.
molnova catalog
related products
  • PSNCBAM-1

    PSNCBAM-1 is a CB1 receptor negative allosteric modulator (EC50 = 0.1 μM) with hypophagic effects in vivo. PSNCBAM-1 can be used for obesity studies.

  • VCE-004.3

    VCE-004.3 (VCE004.3) is a novel semi-synthetic cannabidiol derivative behaving as a dual PPARγ/CB2 agonist and CB1 receptor modulator.

  • OMDM-5

    OMDM-5 is a potent vanilloid receptor type 1 (TRPV1, EC50 = 75 nM) agonist, showing weak ligand activity at cannabinoid type 1 receptor (CB1, Ki=4.9 μM).